The DermaSensor™ device has been specifically designed to analyse skin lesions that you suspect may be malignant. It should not be used to assess other skin conditions such as eczema, psoriasis, acne, rosacea. ichthyosis, vitiligo, hives or seborrheic dermatitis.
Further, the machine learning algorithm has not been trained to analyse skin that you would not typically consider suspicious. The lesions we have used to train the algorithm were suggestive of skin cancer (e.g. melanoma, BCC and SCC) to clinicians trained in assessing skin cancer.